natgillin/translations-raw huggingface dataset:
Strengthen partnerships and collaboration with international actors and initiatives, such as the World Health Organisation and its Strategic Advisory Group of Experts on Immunization (SAGE), the European Technical Advisory Group of Experts on Immunization (ETAGE), the Global Health Security Initiative and Agenda processes (Global Health Security Initiative, Global Health Security Agenda), UNICEF and financing and research initiatives like GAVI the Vaccine Alliance, the Coalition for epidemic preparedness innovations (CEPI) and the Global Research Collaboration for Infectious disease Preparedness (GloPID-R). 
Krepi partnerstva in sodelovanje z mednarodnimi akterji ter pobudami, kot so Svetovna zdravstvena organizacija in njena strateška svetovalna skupina strokovnjakov za imunizacijo (SAGE), evropska tehnična svetovalna skupina strokovnjakov za imunizacijo (ETAGE), postopki pobude in agende za globalno zdravstveno varnost (Global Health Security Initiative, Global Health Security Agenda), UNICEF ter pobude za financiranje in raziskave, kot so partnerstvo Gavi, The Vaccine Alliance, koalicija za inovacije na področju pripravljenosti na epidemije (CEPI) in globalno raziskovalno sodelovanje za pripravljenost na nalezljive bolezni (GloPID-R).
The Recommendation envisages a possibility of establishing a European Vaccine Information Sharing System with a view to developing guidelines on a EU common vaccination schedule, an EU vaccination card and a web-portal with reliable updated information on the benefits and safety of vaccinations. 
Priporočilo predvideva možnost ustanovitve evropskega sistema za izmenjavo informacij o cepljenju, da bi se pripravili smernice o skupnem razporedu cepljenja v EU, evropska knjižica o cepljenju ter spletni portal z zanesljivimi in posodobljenimi informacijami o koristih in varnosti cepiv.
The Recommendation further advocates creating a virtual data warehouse of vaccine needs and stocks which could enable Member States and the Commission to identify available stocks of vaccines in cases of outbreaks or severe shortages and to mutually exchange the surpluses. 
Priporočilo prav tako zagovarja ustanovitev virtualnega podatkovnega skladišča za beleženje potreb po cepivih in njihovih zalog, ki bi državam članicam in Komisiji omogočilo opredelitev razpoložljivih zalog cepiv v primeru izbruha ali resnega pomanjkanja ter medsebojno izmenjavo presežkov.
(15) Directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work lays down minimum requirements to ensure workers' protection, including the need to offer vaccines for those not previously immunised and Directive 2010/32/EU implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU foresees that if the risk assessment reveals that there is a risk to the safety and health of workers due to their exposure to biological agents for which effective vaccines exist, workers should be offered vaccination. 
(15) Direktiva 2000/54/ES o varovanju delavcev pred tveganji zaradi izpostavljenosti biološkim dejavnikom pri delu določa minimalne zahteve za zagotavljanje zaščite delavcev, vključno s potrebo po imunizaciji še necepljenih delavcev, in Direktiva 2010/32/EU o izvajanju okvirnega sporazuma o preprečevanju poškodb z ostrimi medicinskimi pripomočki v bolnišnicah in zdravstvenem sektorju, ki sta ga sklenila HOSPEEM in EPSU, določata, da če je iz ocene tveganja razvidno tveganje za varnost in zdravje delavcev zaradi njihove izpostavljenosti biološkim dejavnikom, za katere obstajajo učinkovita cepiva, bi bilo delavcem treba zagotoviti možnost cepljenja.
(10) Vaccine shortages have direct consequences for the delivery and implementation of national vaccination programmes; Member States face various vaccine supply disruptions; production capacities in the EU remain limited; and difficulties persist in sharing vaccines across borders, while the lack of coordinated forecast planning contributes to demand uncertainty. 
(10) Pomanjkanja cepiv neposredno vplivajo na zagotavljanje in izvajanje nacionalnih programov cepljenja, države članice se soočajo z resnimi motnjami v preskrbi s cepivi, proizvodne zmogljivosti v EU so še vedno omejene, še naprej prihaja do težav pri čezmejni izmenjavi cepiv, neusklajeno načrtovanje potreb pa prispeva k negotovosti povpraševanja.
While national vaccination programmes are planned, organised, and conducted differently across Member States, all EU countries are grappling with these common challenges: declining coverage, supply shortages and growing vaccine hesitancy. 
Čeprav se načrtovanje, organizacija in izvajanje nacionalnih programov cepljenja razlikujejo glede na državo članico, pa se vse države EU soočajo z enakimi izzivi: zmanjševanje precepljenosti, pomanjkljiva preskrba in naraščanje nezaupanja v cepljenje.
It further highlights the need for increased communication and awareness raising activities on the benefits of vaccination. 
Poudarja tudi potrebo po dejavnostih boljšega komuniciranja in ozaveščanja o koristih cepljenja.
[17: Council Conclusions on Common values and principles in European Union Health Systems (2006/C 146/01), http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2006:146:0001:0003:EN:PDF] 
[17: Sklepi Sveta o skupnih vrednotah in načelih zdravstvenih sistemov Evropske unije (2006/C 146/01), http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2006:146:0001:0003:SL:PDF.]
c. Identifying the options for physical stockpiling and engaging in a dialogue with vaccine producing companies on a mechanism to facilitate the stockpiling and availability of vaccines in case of outbreaks taking into account global shortages of essential vaccines; 
c. proučiti možnosti za fizično zalogo cepiv in vzpostaviti dialog s podjetji, ki proizvajajo cepiva, o mehanizmu za lažje skladiščenje cepiv in njihovo razpoložljivost v primeru izbruhov ob upoštevanju svetovnega pomanjkanja osnovnih cepiv;
(5) The rapid spread of disinformation through social media and vocal antivaccination activists have fuelled misconceptions that are shifting the public focus away from the individual and collective benefits of vaccination and the risks posed by communicable diseases, towards increased distrust and fears of unproven side events. 
(5) Hitro širjenje dezinformacij prek družbenih medijev ter glasni nasprotniki cepljenja podžigajo napačne predstave, ki pozornost javnosti odvračajo od individualnih in družbenih koristi cepljenja in tveganj zaradi nalezljivih bolezni ter povzročajo vedno večje nezaupanje v cepljenje in strah pred nedokazanimi stranskimi učinki.
Substantial financial investment and expertise is needed for the development of new innovative vaccines and the improvement or adaptation of existing ones (e.g. improved safety profile, adaptation to different ages, risk groups or pathogens), which makes research and development much more complex, costly and risky. 
Za razvoj novih, inovativnih cepiv in izboljšanje oziroma prilagoditev obstoječih (npr. izboljšani varnostni profil, prilagoditev različnim starostim, skupinam tveganja ali patogenom) so potrebne znatne finančne naložbe in strokovno znanje, zaradi česar so raziskave in razvoj zelo zapleteni, dragi in tvegani.
Under this system, various stakeholders could come together to develop guidelines for a possible core EU vaccination schedule, share common methodologies for monitoring coverage, and launch a web portal with transparent evidence on vaccines benefit and risks including tracking vaccine myths and misinformation. 
V okviru tega sistema bi lahko različne zainteresirane strani skupaj razvile smernice za morebitni temeljni razpored cepljenja v EU, izmenjevale skupne metodologije za spremljanje precepljenosti ter vzpostavile spletni portal s preglednimi dokazi o koristih in tveganjih pri cepljenju, na katerem bi lahko sledile mitom in napačnim informacijam o cepivih.
EN 17 EN 
SL 17 SL
[16: Decision 1082/2013/EU of the European Parliament and of the Council of 22 October 2013 on serious cross-border threats to health and repealing Decision No 2119/98/EC, https://ec.europa.eu/health/sites/health/files/preparedness_response/docs/decision_serious_crossborder_threats_22102013_en.pdf ] 
[16: Sklep št. 1082/2013/EU Evropskega parlamenta in Sveta z dne 22. oktobra 2013 o resnih čezmejnih nevarnostih za zdravje in o razveljavitvi Odločbe št. 2119/98/ES, https://ec.europa.eu/health/sites/health/files/preparedness_response/docs/decision_serious_crossborder_threats_22102013_sl.pdf. ]
b. Engaging with healthcare workers, education stakeholders, social partners and the media as multipliers, to fight complacency and increase trust in immunisation. 
b. sodelovanjem z zdravstvenimi delavci, zainteresiranimi stranmi na področju izobraževanja, socialnimi partnerji in mediji za okrepitev boja proti podcenjevanju nevarnosti necepljenja in za povečanje zaupanja v imunizacijo.
(6) The insufficient vaccination coverage rates of healthcare workers and their adequate training on vaccination must be addressed to ensure their own - and their patients' - protection, in line with national recommendations. 
(6) Za varovanje zdravstvenih delavcev in njihovih pacientov je treba obravnavati nezadostno stopnjo precepljenosti med zdravstvenimi delavci in zagotoviti njihovo ustrezno usposabljanje o cepljenju v skladu z nacionalnimi priporočili.
[9: Council conclusions on vaccination as an effective tool in public health (2014/C 438/04), http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52014XG1206(01)&from=EN ] 
[9: Sklepi Sveta o cepljenju kot učinkovitem načinu zagotavljanja javnega zdravja (2014/C 438/04), http://eur-lex.europa.eu/legal-content/SL/TXT/PDF/?uri=CELEX:52014XG1206(01)&from=SL. ]
(2) In accordance with Article 168(6) TFEU the Council, on a proposal from the Commission may adopt recommendations for the purposes of that Article to improve public health, in relation to in particular fight against major health scourges, monitoring, early warning of, and combating serious cross-border threats to health. 
(2) V skladu s členom 168(6) PDEU lahko Svet na predlog Komisije sprejme priporočila za namene navedenega člena za izboljšanje javnega zdravja, zlasti v povezavi z obvladovanjem močno razširjenih težkih bolezni, nadzorom na veliko čezmejno ogroženostjo zdravja, zgodnjim obveščanjem o taki ogroženosti in bojem proti njej.
To assist Member States in covering short term shortages as a result of, for example, disease outbreaks, underestimating stocks or manufaturing disruptions or extraordinary events, such as an influx of migrants, a concerted EU assistance would be very beneficial. 
Usklajena evropska pomoč bi zelo koristila državam članicam pri odpravi kratkotrajnega pomanjkanja zaradi npr. izbruha bolezni, podcenjevanja zalog ali motenj v proizvodnji ali izrednih dogodkov, kot je pritok migrantov.
In accordance with Article 168(6) TFEU the Council, on a proposal from the Commission may adopt recommendations for the purposes of that Article to improve public health, in relation to in particular fight against major health scourges, monitoring, early warning of, and combating serious cross-border threats to health. 
V skladu s členom 168(6) PDEU lahko Svet na predlog Komisije sprejme priporočila za namene navedenega člena za izboljšanje javnega zdravja, zlasti v povezavi z obvladovanjem močno razširjenih težkih bolezni, nadzorom nad veliko čezmejno ogroženostjo zdravja, zgodnjim obveščanjem o taki ogroženosti in bojem proti njej.
Vaccine Schedules in All Countries of the European Union Online Platform, https://vaccine-schedule.ecdc.europa.eu/ ] 
[5: Evropski center za preprečevanje in obvladovanje bolezni: Vaccine Schedules in All Countries of the European Union Online Platform (spletna platforma z razporedi cepljenja v vseh državah Evropske unije), https://vaccine-schedule.ecdc.europa.eu/. ]
[18: Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 April 2004 establishing a European Centre for Disease Prevention and Control, http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32004R0851&from=EN] 
[18: Uredba (ES) št. 851/2004 Evropskega parlamenta in Sveta z dne 21. aprila 2004 o ustanovitvi Evropskega centra za preprečevanje in obvladovanje bolezni, http://eur-lex.europa.eu/legal-content/SL/TXT/PDF/?uri=CELEX:32004R0851&from=SL.]
Spending on vaccination should be regarded as an essential and smart investment in health, given its broader economic impact and societal value. 
Glede na širši gospodarski vpliv in družbeno vrednost cepljenja bi bilo treba sredstva zanj obravnavati kot ključno in pametno naložbo v zdravje.
[23: Commission High-Level group on Fake News and online disinformation, https://ec.europa.eu/digital-single-market/en/news/high-level-group-fake-news-and-online-disinformation ][24: Commission Communuication on Tackling Online Disinfornation: a European Approach, COM(2018)236] 
][24: Sporočilo Komisije o boju proti dezinformacijam na spletu: evropski pristop, COM(2018) 236.]
Finally, to address shortages and increase supply, the proposal puts forward the idea of creating a virtual data warehouse for Europe on vaccine needs and stocks and a mechanism for mutual exchange of vaccines among Member States; identification of options for a physical vaccine stockpile in case of outbreaks or global shortages of vaccines and envisages working with industry and other stakeholders to improve EU manufacturing capacity of vaccines. 
Predlog za odpravo pomanjkanja in povečanje preskrbe predlaga vzpostavitev virtualnega evropskega podatkovnega skladišča za beleženje potreb po cepivih in njihovih zalog ter mehanizem za medsebojno izmenjavo cepiv med državami članicami, pa tudi proučitev možnosti za fizično zalogo cepiv v primeru izbruhov ali svetovnega pomanjkanja cepiv ter za izboljšanje evropskih proizvodnih zmogljivosti na področju cepiv priporoča sodelovanje z industrijo in drugimi zainteresiranimi stranmi.
Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA - 2 February 2016. 
[6: Evropski center za preprečevanje in obvladovanje bolezni: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA - 2 February 2016 (pomanjkanje brezceličnega cepiva proti oslovskemu kašlju in vpliv na programe imunizacije v EU/EGP - 2. februar 2016).
d. Jointly with stakeholders and industry, improving EU manufacturing capacity and ensuring continuity of supply; 
d. izboljšati proizvodne zmogljivosti EU in zagotoviti neprekinjeno oskrbo skupaj z zainteresiranimi stranmi in industrijo;
Stockholm: ECDC; 2016. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/RRA-shortage-of-aP-containing-vaccines.pdf ][7: WHO Regional Office for Europe, Dealing with vaccine shortages: current situation and ongoing activities. 
][7: Regionalni urad SZO za Evropo: Dealing with vaccine shortages: current situation and ongoing activities.
[25: Resolution 70/1 adopted by the General Assembly of United Nations on 25 September 2015: Transforming our world: the 2030 Agenda for Sustainable Development][26: Joint Statement by the Council and the representatives of the governments of the Member States meeting within the Council, the European Parliament and the Commission (2017/C 210/01) the new European Consensus on Development "Our World, Our Dignity, Our Future"] 
][26: Skupna izjava Sveta in predstavnikov vlad držav članic v okviru Sveta, Evropskega parlamenta in Komisije (2017/C 210/01): novo evropsko soglasje o razvoju „Naš svet, naše dostojanstvo, naša prihodnost".]
[10: Council conclusions on childhood immunisation: successes and challenges of European childhood immunisation and the way forward (2011/C 202/02), http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52011XG0708(02)&from=EN ] 
[10: Sklepi Sveta o otroškem cepljenju: dosežki in izzivi v zvezi z otroškim cepljenjem v Evropi in obeti za naprej (2011/C 202/02), http://eur-lex.europa.eu/legal-content/SL/TXT/PDF/?uri=CELEX:52011XG0708(02)&from=SL. ]
At the same time, production capacity is limited by long lead times; procurement processes remain cumbersome and inefficient and the lack of forecast planning coupled with the variance of vaccination schedules render the demand unpredictable. 
Postopki javnega naročanja so še vedno okorni in neučinkoviti, povpraševanje pa je zaradi nezadostnega načrtovanja potreb ter različnih razporedov cepljenja nepredvidljivo.
With the support of the European Medicine Agency, continuously monitor the benefits and risks of vaccines, at EU level. 
Stalno spremljanje koristi in tveganja pri cepljenju na ravni EU ob podpori Evropske agencije za zdravila.
design EU methodologies and guidance on data requirements for better monitoring of vaccination coverage rates across all age groups, including healthcare workers, in cooperation with the World health Organisation (WHO). 
iii. zasnovala metodologije in smernice EU o zahtevah po podatkih za boljše spremljanje stopenj precepljenosti v vseh starostnih skupinah, vključno z zdravstvenimi delavci, v sodelovanju s Svetovno zdravstveno organizacijo (SZO), zbirala in izmenjevala tovrstne podatke na ravni EU;
Draft Motion for a Resolution on vaccine hesitancy and the drop in vaccination rates in Europe (2017/2951RSB) 19 04 2018] 
[22: Evropski parlament, Odbor za okolje, javno zdravje in varnost hrane: Draft Motion for a Resolution on vaccine hesitancy and the drop in vaccination rates in Europe (osnutek predloga resolucije o nezaupanju v cepljenje in upadanju stopenj precepljenosti v Evropi) (2017/2951RSB), 19. 4.
[3: Directive 2000/54/EC of the European Parliament and of the Council of 18 September2000 on the protection of workers from risks related to exposure to biological agents at work, http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32000L0054&from=EN] 
[3: Direktiva Evropskega parlamenta in Sveta 2000/54/ES z dne 18. septembra 2000 o varovanju delavcev pred tveganji zaradi izpostavljenosti biološkim dejavnikom pri delu, http://eur-lex.europa.eu/legal-content/SL/TXT/PDF/?uri=CELEX:32000L0054&from=SL.]
[19: Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:311:0067:0128:en:PDF ][20: Regulation 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/reg_2004_726/reg_2004_726_en.pdf ] 
][20: Uredba (ES) št. 726/2004 Evropskega parlamenta in Sveta z dne 31. marca 2004 o postopkih Skupnosti za pridobitev dovoljenja za promet in nadzor zdravil za humano in veterinarsko uporabo ter o ustanovitvi Evropske agencije za zdravila, https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/reg_2004_726/reg_2004_726_sl.pdf. ]
Impact of shortages and solutions set up by countries, SAGE April 20016 Meeting http://www.who.int/immunization/sage/meetings/2016/april/2_Benes_shortages_SAGE_Apr2016.pdf ][8: Vaccines Europe, The EU Vaccine Industry in Figures 2014, https://www.vaccineseurope.eu/about-vaccines/vaccines-europe-in-figures/ ] 
Vpliv pomanjkanja in rešitve držav, sestanek SAGE, april 2016), http://www.who.int/immunization/sage/meetings/2016/april/2_Benes_shortages_SAGE_Apr2016.pdf.
There is also specific emphasis on measles vaccination given the current outbreak in Europe. 
Glede na trenutni izbruh v Evropi je poseben poudarek na cepljenju proti ošpicam.
[4: European Centre for Disease Prevention and Control. 
[4: Evropski center za preprečevanje in obvladovanje bolezni: Seasonal influenza vaccination in Europe.
There are several drivers contributing to low levels of vaccine coverage and preventable immunisation gaps: 
K nizki stopnji precepljenosti in nezadostni imunizaciji, ki jo je mogoče preprečiti, prispevajo številni dejavniki:
The rapid spread of disinformation through online media and vocal vaccine deniers has also fuelled misconceptions. 
Napačne predstave dodatno spodbujajo hitro širjenje dezinformacij prek spletnih medijev in glasni nasprotniki cepljenja.
Concerted efforts are needed from all Member States and stakeholders to boost vaccine coverage, reduce immunisation gaps and increase confidence and trust in vaccination. 
Za spodbujanje precepljenosti in povečanje imunizacije ter okrepitev zaupanja v cepljenje so potrebna skupna prizadevanja vseh držav članic in zainteresiranih strani.
Section III - Commission 
Oddelek III − Komisija
Support may be used to finance inter alia the following actions: 
Podpora se lahko med drugim uporabi za financiranje naslednjih ukrepov:
cross-border cooperation to alleviate the pressure on health systems in the most affected EU regions; 
čezmejno sodelovanje za zmanjšanje pritiska na zdravstvene sisteme v najbolj prizadetih regijah EU;
Further reinforcement of the Union Civil Protection Mechanism (within the Union) 
Dodatna okrepitev mehanizma Unije na področju civilne zaščite (znotraj Unije)
This amendment of Regulation No 1311/2013 should enter into force at the latest on the same day as the final adoption of this DAB.] 
Ta sprememba Uredbe št. 1311/2013 bi morala začeti veljati najpozneje na dan končnega sprejetja tega PSP.]
Having regard to: 
Evropska komisija ob upoštevanju:
The Flexibility Instrument for an amount of EUR 243,0 million; and 
instrument prilagodljivosti v znesku 243,0 milijona EUR; in
It will be available to all Member States and will be used in case of insufficient national capacity. 
Na voljo bo vsem državam članicam in bo uporabljena v primeru, da države članice nimajo zadostnih zmogljivosti.
CHANGES TO THE STATEMENT OF REVENUE AND EXPENDITURE BY SECTION 
SPREMEMBE IZKAZA PRIHODKOV IN ODHODKOV PO ODDELKIH
The changes to the general statement of revenue and section III are available on EUR-Lex (https://eur-lex.europa.eu/budget/www/index-en.htm). 
Spremembe splošnega izkaza prihodkov in oddelka III so na voljo na portalu EUR-Lex (https://eur-lex.europa.eu/budget/www/index-sl.htm).
Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July 2018 on the financial rules applicable to the general budget of the Union (…), and in particular Article 44 thereof, 
Uredbe (EU, Euratom) 2018/1046 Evropskega parlamenta in Sveta z dne 18. julija 2018 o finančnih pravilih, ki se uporabljajo za splošni proračun Unije (…), in zlasti člena 44 Uredbe,
It was designed as a general purpose tool to fight crises within the EU and intervenes only in exceptional circumstances of severe difficulties. 
Zasnovan je bil kot orodje za splošno uporabo v boju proti krizam v EU, z njim pa se posreduje le v izjemnih okoliščinah hudih težav.
boosting the swift development of medication and testing methods; 
spodbujanje hitrega razvoja zdravil in metod testiranja;
The Emergency Support Instrument (ESI) was created in March 2016 and was activated for a period of 3 years to address the emergency situation which had arisen following the massive influx of refugees in Greece. 
Instrument za zagotavljanje nujne pomoči (ESI) je bil vzpostavljen marca 2016 in aktiviran za obdobje 3 let za odpravo izrednih razmer, ki so se pojavile po množičnem prihodu beguncev v Grčijo.
Providing emergency support to Member States through the re-activation of the Emergency Support Instrument within the Union 
Zagotavljanje nujne pomoči državam članicam s ponovnim aktiviranjem instrumenta za zagotavljanje nujne pomoči v Uniji
meeting the transport needs for protective gear to be imported from international partners as well as transport across the EU; 
izpolnjevanje potreb glede prevoza zaščitne opreme, uvožene od mednarodnih partnerjev, in prevoza po EU;
The rescEU direct grant will provide 100 % financing from the EU budget, which includes full financing for development of the these capacities and full financing of deployment. 
Neposredna nepovratna sredstva mehanizma rescEU bodo zagotovila 100-odstotno financiranje iz proračuna EU, kar vključuje polno financiranje razvoja teh zmogljivosti in polno financiranje njihove uporabe.